The Myostatin gene: an overview of mechanisms of action and its relevance to livestock animals by Aiello, D. et al.
The Myostatin gene: an overview of 
mechanisms of action and its relevance to  
livestock animals 
Article 
Accepted Version 
Aiello, D., Patel, K. and Lasagna, E. (2018) The Myostatin 
gene: an overview of mechanisms of action and its relevance 
to livestock animals. Animal Genetics, 49 (6). pp. 505­519. 
ISSN 1365­2052 doi: https://doi.org/10.1111/age.12696 
Available at http://centaur.reading.ac.uk/77388/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work.  See Guidance on citing .
To link to this article DOI: http://dx.doi.org/10.1111/age.12696 
Publisher: Wiley 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
1 
 
Review: The Myostatin gene: an overview of mechanisms of action and its 1 
relevance to livestock animals 2 
D. Aiello1, K. Patel2 and E. Lasagna1 3 
 4 
1
 Dipartimento di Scienze Agrarie, Alimentari e Ambientali, Università degli Studi di 5 
Perugia, Borgo XX Giugno 74, 06121, Perugia, Italy 6 
2
 School of Biological Sciences, University of Reading, Berkshire, RG6 6UB, United 7 
Kingdom 8 
 9 
Corresponding author: Emiliano Lasagna. Fax: +39 075 5857122. Tel: +39 075 10 
5857102. E-mail address: emiliano.lasagna@unipg.it 11 
 12 
  13 
2 
 
 14 
Summary 15 
Myostatin, also known as Growth Differentiation Factor 8, a member of the 16 
Transforming Growth Factor-beta (TGF-β) super-family is a negative regulator of 17 
muscle development. Myostatin acts at key points during pre- and post-natal life of 18 
amniotes which ultimately determine the overall muscle mass of an animal. Mutations 19 
have already demonstrated the impact of attenuating Myostatin activity on muscle 20 
development. A number of large animals including cattle, sheep, dogs and humans 21 
display the ‘double muscled’ phenotype due to mutations in the Myostatin gene. Here 22 
we firstly give an overview of the molecular pathways regulated by Myostatin that 23 
control muscle development. Then we describe the natural mutations and their 24 
associated phenotypes as well as the physiological influence of altering Myostatin 25 
expression in livestock animals (cattle, sheep, goat, horse, pig, rabbit and chicken). 26 
Knowledge of null alleles and polymorphisms in the Myostatin gene are of great 27 
interest in the animal breeding field and it could be utilized to improve meat 28 
production in livestock animals. 29 
 30 
Keywords: double muscling, single nucleotide polymorphisms, muscle hypertrophy, 31 
muscle hyperplasia, meat production. 32 
 33 
Introduction 34 
Myostatin 35 
Myostatin (MSTN), also known as Growth and Differentiation Factor 8 (GDF8), is one 36 
of the major regulators of skeletal muscle development (Beyer et al., 2013). The 37 
MSTN gene (MSTN) is highly conserved among mammalian species and it acts in an 38 
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almost unique manner to reduce muscle size. MSTN-deficient animals display an 39 
increase in skeletal muscle mass known as double-muscling (DBM). Mutations in 40 
MSTN have been described in numerous species including dog (Mosher et al., 41 
2007), sheep (Kijas et al., 2007), cattle (Grobet et al., 1997), pig (Stinckens et al., 42 
2008) as well as in one human (Schuelke et al., 2004). 43 
 44 
Myostatin signalling pathway and its control of skeletal muscle development 45 
MSTN is expressed in many tissues (including the mammary gland) but most 46 
prominently in skeletal muscle (Ji et al., 1998). The MSTN has been highly conserved 47 
throughout evolution and comprises 3 exons and 2 introns. 48 
In all species reported in this review, MSTN exons code for a 375 amino acid latent 49 
protein which undergoes significant post-translational modification in order to become 50 
biologically active (Wolfman et al., 2003). Firstly, the polypeptide undergoes 51 
intracellular homodimerization through the formation of disulphide bonds. Thereafter 52 
it is cleaved to form the N-terminal propeptide region and the C-terminal mature 53 
region. The 12- KDa C-terminal mature fragment of MSTN initiates an intracellular 54 
signalling cascade through its ability to bind and activate the Activin type II receptor 55 
at the cell surface (ActRIIB and to a lesser extent ActRIIA). Subsequent 56 
autophosphorylation of the ActRIIB leads to the recruitment and activation of low 57 
affinity type I receptor for Activin ALK-4 or ALK-5. Activated type I receptor kinase 58 
phosphorylates the transcription factors Smad2 and Smad3, allowing them to interact 59 
with Smad4 (co-Smad) and translocate to the nucleus, to activate target gene 60 
transcription. Importantly the activation of the MSTN receptor also inhibits Akt 61 
(protein kinase B) activity, a major determinant in muscle protein synthesis and cell 62 
proliferation. Enlargement of muscle fibre size, a process called fibre hypertrophy (or 63 
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simply hypertrophy) is in large part controlled by Akt activity (Trendelenburg et al., 64 
2009). Myogenic differentiation is a highly orchestrated sequential program that 65 
ultimately generates mature skeletal muscle. Highly proliferative muscle precursors 66 
which arise during embryogenesis differentiate into myoblasts. The commitment of 67 
the myogenic lineage is regulated by Muscle Regulatory Factors (MRFs) a collective 68 
group of helix-loop-helix transcription factors; namely, MyoD, Myf5, Myogenin and 69 
MRF4 (Fig. 1). Additionally, exit from the cell cycle is a vital step during myoblast 70 
differentiation (Bryson-Richardson & Currie, 2008). 71 
MSTN regulates muscle development at key points during the process of pre-natal 72 
muscle development: muscle precursor proliferation, myoblast proliferation and 73 
differentiation. Studies by Amthor et al. (2002) have shown that ectopic expression (in 74 
limb muscle) of MSTN down regulates Pax3; a key marker of proliferating muscle 75 
precursors (Amthor et al., 2002). Additionally, MSTN upregulates p21 expression, 76 
which ultimately inhibits proliferation of MyoD expressing myoblasts (Thomas et al., 77 
2000). Of relevance to this review is the relationship between MyoD activity and the 78 
expression of MSTN. MyoD is an important regulator of MSTN expression during 79 
myogenesis. This is demonstrated by a critical role of E-box motifs that were 80 
identified in the MSTN promoter region; these motifs are known to be the binding 81 
sites for basic helix-loop-helix transcription factors (MRFs) (Hu et al., 2013). 82 
The interrelationship between MyoD and MSTN ensure that promiscuous 83 
differentiation mediated by an over-active MyoD induced cascade is checked by the 84 
up-regulation of MSTN. Therefore MSTN serves to limit the size of both the myoblast 85 
precursor (Pax3+/MyoD+) and myoblast (Pax3-/MyoD+) pools. Down-regulating the 86 
expression of MSTN would lead to an expansion of both populations (Amthor et al., 87 
1999). 88 
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Examination of mouse development shows that muscle mass is determined by the 89 
ability of myoblasts to form fibres, a process that occurs in two phases; primary and 90 
secondary fibre formation. Matsakas et al. (2010) have shown an increase in the 91 
myoblast pool, just before the fibre formation process in Myostatin null mouse (Mstn-/-92 
) embryos, which supports the development of extranumerary primary and secondary 93 
myofibres. Any programme that promotes an increase in fibre formation is called fibre 94 
hyperplasia or simply, hyperplasia (Amthor et al., 2002). Therefore the Mstn-/- mouse 95 
displays hyperplasia as a consequence of developing an increased number of mono-96 
nucleated muscle cells (Matsakas et al., 2010). 97 
Shortly before birth, muscle in Mstn-/- mice not only contain extra muscle fibres, but 98 
also each fibre has undergone a small, albeit significant, increase in size (18%). 99 
However this is not enough to explain why the muscles in this species often weigh 2-100 
3 times more than their normal counterpart (Omairi et al., 2016). The resolution to 101 
this issue comes by examining the size of each muscle fibre in adult mice. This 102 
reveals that in the mouse, the increased muscle mass has arisen due to a 103 
combination of a pre-natal increase in the number of fibres (hyperplasia) and a 104 
precocious post-natal increase (43%) in the size of each fibre (hypertrophy) 105 
(McPherron & Lee, 1997). 106 
These studies are extremely insightful when attempting to determine the cellular 107 
mechanism underpinning double muscling in large mammalian species harbouring a 108 
MSTN mutation (Elashry et al., 2012). They predict that for an animal to develop fibre 109 
hyperplasia and a small degree of hypertrophy as a consequence of a MSTN 110 
mutation, the gene must normally be expressed and properly translated into a mature 111 
form during pre-natal development. However, in order to display significant fibre 112 
hypertrophy these conditions need to be satisfied during post-natal life. If the mouse 113 
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is taken as a guide, then changes in fibre number and small changes in fibre 114 
diameter (less than 20%) can be explained by pre-natal action of MSTN. In cattle, 115 
very low levels of MSTN are detected from day 15 to day 29 embryos, and increased 116 
expression is detected from day 31 onwards (Kambadur et al., 1997). The increase 117 
of MSTN expression in the bovine embryos is thought to occur at a gestational stage 118 
when primary myoblasts are starting to fuse and differentiate into myofibres. 119 
Therefore the null mutation in the bovine MSTN lead to hyperplasia. 120 
 121 
Double muscling phenotypes 122 
The term hypertrophy has often been used to describe large mammalian species, 123 
which display at the gross anatomical level, the enlargement of muscle. 124 
Mechanistically this term has been used loosely, since in many cases enlargement of 125 
muscle is solely through pre-natal muscle hyperplasia without any post-natal fibre 126 
hypertrophy. 127 
DBM in large animals has been reported in several species. Generally, muscle with a 128 
large superficial area tends to be the most enlarged, while deeper muscles tend to be 129 
reduced in size relative to normal muscle (Ouhayon & Beaumont, 1968). Large 130 
commercially important DBM animals, especially cattle, have an excellent 131 
conformation and an extremely high carcass yield, coinciding with a reduced internal 132 
organ mass (Fiems, 2012). 133 
However, these animals are more susceptible to respiratory disease, urolithiasis, 134 
lameness, nutritional stress, heat and dystocia resulting in lower robustness (Holmes 135 
et al., 1973). Also the reproductive performance can be influenced by hypertrophy: 136 
i.e. in the South Devon breed, the gestation period for DBM calves is longer, resulting 137 
in offspring with higher birth weights than the normal calves, also evidenced by the 138 
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higher instances of dystocia with high mortality rates if births are unassisted; the 139 
findings highlighted therefore that the segregating alleles at the MSTN have 140 
significant effects on calving ease in this breed (Wiener et al., 2002). 141 
DBM cattle showed signs of fatiguing faster than normal cattle during forced 142 
exercise; relating to metabolic acidosis, because of a reduced blood circulation 143 
leading to a deficiency in the transport of oxygen and a reduction of aerobic 144 
metabolic activity in the muscle (Holmes et al., 1973). DBM cattle have in fact an 145 
increase in the proportion of fast twitch glycolytic fibres, resulting in a faster and more 146 
glycolytic phenotype (Girgenrath et al., 2005). 147 
Mutations in the MSTN are responsible for DBM in other large animals including one 148 
case in humans. In the latter, Schuelke et al. (2004), observed that a G to A transition 149 
at nucleotide gIVS1+5 caused extraordinary muscling in a young boy, especially in 150 
the thighs and upper arms. No health problems were reported in the patient and the 151 
testosterone and IGF-1 levels were normal. In dogs known as "bully" whippets, a 2-152 
bp deletion was discovered in the third exon of the MSTN is associated with the DBM 153 
phenotype. This deletion removes nucleotides 939 and 940 within exon three and 154 
leads to a premature stop codon at amino-acid 313 instead of the normal cysteine, 155 
removing 63 amino acids from the predicted 375-aa protein (Mosher et al., 2007). A 156 
gene targeting approach using the CRISPR/Cas9 system has been used to create 157 
MSTN null Beagles; although mutant dogs displayed the DMB phenotype, very little 158 
detail is available regarding their cellular phenotype (Zou et al., 2015). Due to the 159 
effects of MSTN on muscle mass, growth and other traits, the variations in MSTN 160 
expression levels in skeletal muscles are of great interest in the animal breeding 161 
field. Knowledge of null alleles and polymorphisms in the MSTN has been utilized to 162 
improve the selection of beef cattle and sheep (Georges, 2010). The aim of this 163 
8 
 
section of the review is to describe known double-muscling in livestock animals that 164 
harbour MSTN mutations. 165 
 166 
Mutations in the Myostatin gene in cattle 167 
Monogenic determination of muscular hypertrophy in Belgian Blue cattle was first 168 
described in the 1980’s (Hanset & Michaux, 1985; Grobet et al., 1997). Double 169 
muscling was shown to be inherited as a single major autosomal locus which 170 
nevertheless was affected by several modifier loci manifesting in incomplete 171 
penetrance. The causal loss of function mutation in Belgian Blue MSTN, located on 172 
chromosome 2, was first reported by Grobet (1997) followed shortly thereafter by the 173 
study of McPherron and Lee who not only substantiated the finding of Grobet but 174 
also reported a missense mutation in exon 3 in the Piedmontese breed MSTN 175 
(McPherron & Lee, 1997). Approximately 20 different types of genetic variants 176 
(deletions, insertions and nucleotide substitutions, also known as single nucleotide 177 
polymorphisms - SNPs) have been identified in the bovine MSTN. Some of these 178 
genetic variants give rise to muscular hypertrophy by inactivation of the gene (Grobet 179 
et al., 1997). Mutated alleles and inactive MSTN have a significant association with 180 
growth speed and carcass favourite traits, so these polymorphisms could be used in 181 
beef cattle in order to increase the quality and quantity of meat (Mirhoseini & Zare, 182 
2012). In the view of quality meat production, this is an outstanding trait, since these 183 
animals produce not just more, but leaner and more tender meat (Kobolák & Gócza, 184 
2002). The carcass and meat quality traits are superior in these animals because of a 185 
reduction in fat (decreased by 50%), muscle mass increase (by 20%) lower 186 
proportions of bone and also less connective tissue, which contributes to tenderness 187 
(McPherron & Lee, 1997; Vincenti et al., 2007). However, dystocia-related problems 188 
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are often observed in DBM cattle because hyperplasia occurs before birth, resulting 189 
in larger calves (Deveaux et al., 2001). Homozygous DBM animals manifest more 190 
problems of dystocia than heterozygous. Therefore in order to generate homozygous 191 
animals and at the same time keep costs down as well as reducing calve death 192 
probability, it is worth considering mating heterozygous animals (Bellinge et al., 193 
2005). 194 
A summary of the detected genetic variants in cattle is reported in Table 1. 195 
 196 
Double muscled cattle breeds 197 
Belgian Blue 198 
The breed in which this muscular hypertrophy and its effects have been analysed 199 
most extensively is the Belgian Blue breed, which has been systematically selected 200 
for double muscling to the point of fixation in many herds. Research by Grobet et al. 201 
(1997) revealed an 11-bp deletion (nucleotides 821-831) in the open reading frame of 202 
the Belgian Blue MSTN allele which results in the loss of 3 amino acids (275, 276, 203 
and 277) and a frameshift after amino acid 274. The frameshift leads to a stop codon 204 
after amino acid 287. Work by Wegner et al. (2000) showed that Semitendinosus 205 
from Belgian Blue was 1.6 times the weight of normal breeds solely due to an 206 
increase in muscle fibre number. Indeed, muscle fibre size from the Belgian Blue was 207 
actually smaller than other breeds (Wegner et al., 2000). Furthermore, these animals 208 
have less collagen and connective tissue than the normal animals. The carcass fat 209 
content in these animals is significantly lower than in normal cattle, especially 210 
intramuscular fat (marbling) being influenced by the DBM phenotype with a strong 211 
reduction of subcutaneous and internal fat tissues (Mirhoseini & Zare, 2012). The 212 
results of many studies in fact have indicated that MSTN plays key roles in not only 213 
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myogenesis but also adipogenesis. MSTN deletion and inhibition in animals mainly 214 
lead to increased muscle mass and reduced fat mass (Deng et al., 2017). 215 
In beef cattle production, crossing with Belgian Blue cattle shows that although the 216 
gene is recessive and monofactorial, its effect is apparent even in heterozygous 217 
animals due to its partial dominance (Kobolák & Gócza, 2002). 218 
The same mutation was also found in the Asturiana de los Valles (AV), a Spanish 219 
beef cattle breed. MSTN polymorphisms in the AV breed have been described and 220 
its diffusion into the breed has been continuous due to economic reasons (Grobet et 221 
al., 1997). 222 
 223 
Piedmontese 224 
In Piedmontese cattle the double-muscled phenotype is an inherited condition 225 
associated with a G to A mutation on nucleotide 938 (in exon 3) which translates to 226 
C313Y in a highly conserved cysteine-knot structural motif region of the protein. This 227 
is in the pre-helix loop, a region known to be important for ALK4/5 receptor 228 
interaction (Cash et al., 2012). The mutation alters the function of MSTN, which 229 
disrupts a disulphide bridge that is essential for the correct conformation of the 230 
protein (Kambadur et al., 1997). This breed has been systematically selected for 231 
double muscling to the point of fixation in many herds (> 96% homozygous in the 232 
Piedmonte region in Italy), but variability in muscle mass is still present (Miretti et al., 233 
2013). Several studies support the notion that the double muscling phenotype, a 234 
partially recessive trait, causes the relatively large effects on carcass conformation, 235 
without a negative effect on calving, compared with animals with no copies of the 236 
mutated allele (Casas et al., 1998). 237 
 238 
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Marchigiana 239 
The Marchigiana is one of the most important Italian beef cattle breeds and it is 240 
renowned for its large body size, high weight daily gains and superior carcass 241 
dressing percent. Marchigiana breed have a G to T transversion mutation at 242 
nucleotide 874 in exon 3 (g.874G>T), translating to E291X in the MSTN. This point 243 
mutation has a remarkable effect on the MSTN as it changes a codon for glutamic 244 
acid into a stop codon (Marchitelli et al., 2003). In Marchigiana, as in the other double 245 
muscling breeds, the MSTN genotypes yield three different and distinct phenotypes. 246 
The homozygous G/G displays the normal phenotype whereas the T/T genotype 247 
manifests as a double muscled body shape while maintaining its small frame, and is 248 
frequently associated with skeletal defects and serious survival problems due to 249 
macroglossia and hypoplasia of the heart, lungs and other vital organs. The 250 
heterozygous genotype (G/T) produces a well-muscled and large body structure and 251 
excellent conformation without any of the above mentioned defects. Therefore, the 252 
heterozygous animals are frequently selected as sires (Cappuccio et al., 1998). 253 
Moreover heterozygous animals show a better meat quality than animals with a 254 
normal genotype (Vincenti et al., 2007). Therefore they could be useful for breeders 255 
to plan the matings to obtain a higher number of heterozygous animals. Obviously 256 
this is possible only if the genotype at the MSTN locus of each animal is available. 257 
Additionally two different SNPs have been found in the promoter region: g.-371T>A 258 
and g.-805G>C, although Sarti et al. (2014) reported that these substitutions may not 259 
be useful to be considered in the selection criteria, because there is no correlation 260 
with productive traits or due to their homozygous genotype. 261 
 262 
Other cattle breeds 263 
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An 11 bp deletion (nt821(del11)) resulting in a truncation of the bioactive C-terminal 264 
domain of the protein has been found in Blonde d'Aquitaine, Limousine, and 265 
Parthenaise and Rubia Gallega breeds (Kambadur et al., 1997; Dunner et al., 2003). 266 
A recent study (Bouyer et al., 2014) identified an unexpected mutation in the MSTN 267 
in Blonde D’Aquitaine cattle. The mutant allele is highly expressed leading to an 268 
abnormal transcript consisting of a 41-bp inclusion between the exons 2 and 3, with a 269 
premature termination codon predicted to translate into a protein lacking the entire 270 
bioactive region. 271 
An additional transversion mutation (g.433C>A) in Limousine breed has been 272 
described that was shown to be functionally associated with the increased muscle 273 
mass and carcass yield without any associated reproductive disadvantages (Sellick 274 
et al., 2007; Esmailizadeh et al., 2008; Vankan et al., 2010). 275 
As in Piedmontese cattle, a G to A transition at nucleotide position 938 has been 276 
reported in Gasconne (Kambadur et al., 1997; Dunner et al., 2003). An 277 
insertion/deletion at position 419 replacing 7 bp with an unrelated stretch of 10 bp 278 
was reported in Maine-Anjou cattle, resulting in a premature stop codon in the N-279 
terminal latency-associated peptide at amino-acid position 140 (nt419 (del7- ins10)) 280 
(McPherron & Lee, 1997). Additionally, a transversion (G to T) at nucleotide position 281 
676, also causing a premature stop codon in the same N-terminal latency-associated 282 
peptide at amino-acid position 226 (E226X) was identified in the same breed (Grobet 283 
et al., 1997). Charolaise and Limousine have a C to T transition at nucleotide position 284 
610 yielding a premature stop codon in the N-terminal latency associated peptide at 285 
amino-acid positions 204 (Q204X) (Cappuccio et al., 1998). In addition to the genetic 286 
variants found in Bos taurus, 14 polymorphisms (three in exon one, seven in exon 287 
two, and four in exon three) have been reported in the coding part of the MSTN in 288 
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Nellore cattle (Bos indicus) genome. However, whether these polymorphisms are 289 
functional mutations still remains to be elucidated (Grisolia et al., 2009). 290 
 291 
Double muscling in sheep 292 
The MSTN is located at the end of the long arm (2q32.2 locus) on chromosome 2 in 293 
the sheep (Ovis aries) (Bellinge et al., 2005). During the past decade a total of 77 294 
MSTN SNPs have been reported in various sheep breeds such as Texel, Norwegian 295 
Spælsau, commercial New Zealand sheep breeds and Latvian Darkhead (Kijas et al., 296 
2007, Sjakste et al., 2011; Han et al., 2013), and the majority of these SNPs are 297 
located in the non-coding regions of the gene. The exception is a 1-bp deletion 298 
identified in nucleotide position 960 in the MSTN of Norwegian White Sheep and 299 
c.101G/A in New Zealand Romney, c.120insA (Boman et al., 2009). Lastly in 2018, 300 
Trukhachev et al., described for the first time eight variations in non-coding regions of 301 
MSTN in the Stavropol Merino, a breed used for meat production in Russia. A 302 
summary of the detected genetic variants in sheep is reported in Table 2. 303 
 304 
Texel 305 
Belgian Texel sheep muscle fibres show enlargement and therefore can be 306 
considered to have fibre hypertrophy. Texels are utilized extensively as a terminal 307 
crossbreed because of their exceptional conformation and potential to produce 308 
higher-yielding carcasses with increased lean and decreased fat content (Leymaster 309 
& Jenkins, 1993). Analysing the MSTN revealed no nucleotide differences in the 310 
coding regions between DBM and normally muscled breeds (Kijas et al., 2007). This 311 
suggests that genetic variation located outside the coding regions plays a more 312 
important role in the regulation of muscle development in contrast to cattle, where 313 
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MSTN loss of function variants have been found within the three coding exons 314 
(Grobet et al., 1997). Quantitative trait locus (QTL) analysis in Texel sheep 315 
characterized a mutation (g.6723G>A) in the 3’ UTR (Untranslated Region) of the 316 
MSTN on chromosome 2 which has an effect on muscle mass. This creates a target 317 
site for miR1 and miR206; microRNAs (miRNAs) that are highly expressed in skeletal 318 
muscle (Kijas et al., 2007). Other genetic variants have also been found including 319 
c.*1232A, g+391G>T and another 18 SNPs: g.2449C>G; g.2379C>T; g.1405A>T; 320 
g.1402G>A; g.1214C>T; g.1129C>T; g.41A>C; g.39T>C; g+474C>T; G+613T>C; 321 
g+616G>A; g+619T>C; g+622T>C; g+632G>T; g+696C>T; g+3135C>T; 322 
g+4036A>C; g+4044C>T (Kijas et al., 2007). 323 
 324 
Norwegian sheep 325 
The DBM phenotype in Norwegian white sheep was described to have extraordinary 326 
over-development of the muscles, particularly on the hindquarters. Investigations 327 
showed that these animals have not only extremely low levels of subcutaneous fat, 328 
but also decreased internal fatty tissues. The DBM animals had lower bone mass 329 
compared with the wild type animal. Sequence analysis revealed a 1-bp deletion in 330 
the MSTN at nucleotide position 960 in DBM individuals. The deletion of a G residue 331 
(c.960delG) disrupted the reading frame from amino acid 320 onwards and produced 332 
a premature stop codon at amino acid position 359 (compared to position 375 in the 333 
wild type animals) (Boman & Vage, 2009). 334 
The same MSTN 3'-UTR mutation (c.2360G>A) identified in Texel sheep was also 335 
found in the Norwegian breed but with a less profound effect (Boman & Vage, 2009). 336 
However a similar phenotype of increased muscle mass and fat was found in 337 
Norwegian Spælsau sheep. The sequencing of the MSTN coding region revealed a 338 
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1-bp insertion at nucleotide position 120 (c.120insA) in DBM animals. The insertion of 339 
an adenine residue disrupts the reading frame from amino acid position 40 onwards, 340 
and generates a premature stop codon at amino-acid position 49 (Boman & Vage, 341 
2009). 342 
 343 
New Zealand 344 
A comprehensive investigation of polymorphisms in MSTN in a diverse range of 345 
sheep breeds (New Zealand Romney, Coopworth, Corriedale, Dorper, Perendale, 346 
Suffolk, Merino, Dorset Down, Poll Dorset, Texel and other NZ cross-bred sheep) 347 
was performed using polymerase chain reaction-single strand conformational 348 
polymorphism (PCR-SSCP) analysis and DNA sequencing. A total of 28 nucleotide 349 
substitutions were identified from nucleotide c.-1199 (in the promoter region) to 350 
c.*1813 in the 3’UTR. Of these, three were located in the promoter region, three in 351 
the 5’UTR, 11 in intron 1, five in intron 2 and five in the 3’ UTR. Ten new substitutions 352 
have been reported: c.-959C>T, c.-784A>G, c.373+563A>G, c.373+607A>G, c.374-353 
654G>A, c.374-54T>C, c.748-54T>C, c.*83A>G, c.*455A>G and c.*709C>A (Han et 354 
al., 2013). 355 
The other 18 substitutions had been reported previously. These include c.101G>A 356 
which was already found in NZ Romney by Zhou et al. (2008) and also in Merino, 357 
Corriedale and NZ cross-bred sheep (Clop et al., 2006; Kijas et al., 2007). In NZ 358 
Romney a further two SNPs c.-2449G/C and c.-2379T/C were detected (Wang et al., 359 
2016). The SNP c.*123A observed in NZ cross-bred sheep was also reported in 360 
Texel (Kijas et al., 2007), Charollais sheep from Britain (Hadjipavlou et al., 2008), 361 
White Suffolk, Poll Dorset and Lincoln breeds from Australia and showed significant 362 
16 
 
association with DBM phenotype as well as the other substitution c.373+18 T>G, 363 
reported in Texel sheep (Clop et al., 2006). 364 
 365 
Other sheep breeds 366 
Zel sheep, a meat breed in northern Iran, has a polymorphism in intron 2 as does the 367 
Iranian Baluchi sheep (Dehnavi et al., 2012). Three polymorphic sites in Indian sheep 368 
have been identified in the 5'UTR, exon 1 and exon 2 regions. Both SNPs in the 369 
exonic region were found to be non-synonymous. The genetic variants c.539T>G and 370 
c.821T>A were in the exon 1 and exon 2, respectively (Pothuraju et al., 2015). All 371 
these genetics variants are not significantly associated with DBM phenotype. 372 
 373 
Myostatin polymorphisms in goat 374 
Several studies investigated the allelic variation in the goat MSTN. A 5 bp indel (1256 375 
TTTTA/-) was identified in 5’UTR region in Boer, Matou, Haimen and Nubi goat 376 
breeds, and a substitution (1388 T/A) in exon 1 region was detected only in Boer 377 
(Zhang et al., 2012). Two novel single nucleotide polymorphisms were also identified 378 
in Boer and Anhui white goat: g.197G>A, a substitution located in the 5’-UTR, and 379 
345A>T in the exon 1 (Zhang et al., 2013). A thorough investigation was conducted 380 
in 22 different goat breeds (Inner Mongolia Cashmere, Liaoning Cashmere, Taihang 381 
Mountain, Chengde Polled, Jining Grey, Tibetan, Chengdu Brown, Jianchang Black, 382 
Guizhou White, Guizhou Black, Longlin, Duan goat, Leizhou, Matou, Yichang White, 383 
Shannan White, Nanjiang Brown, Angora, Toggenburg, Nubian, Saanen and Boer 384 
goat) and a total of eight SNPs were detected (A1980G, G1981C, A1982G, G1984T, 385 
A2121G, T2124C, G2174A and A2246G) (Li et al., 2006). Recently Nguluma et al. 386 
(2018) detected a polymorphic site T298C in the Boer goat population: the authors 387 
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concluded that the potential association of this polymorphism in MSTN with growth 388 
performance could not be confirmed and that other genes for growth could be 389 
responsible for the observed variation. A summary of the detected genetic variants in 390 
goat is reported in Table 3. 391 
 392 
Myostatin polymorphisms in horse 393 
Hosoyama et al. (2002) isolated and sequenced MSTN cDNA from a Thoroughbred 394 
horse which was mapped to chromosome 18. Mutations in the equine MSTN have 395 
been identified and are associated with racing phenotypes influencing racing 396 
performance and muscle fibre proportions (Petersen et al., 2013). Dall’Olio et al. 397 
(2010) sequenced in 16 horse breeds (Rapid Heavy Draft, Noric, Bardigiano, 398 
Haflinger, Lipizzan, Murgese, Tolfetano, Uruguayan Creole, Italian Saddle, 399 
Maremmano, Quarter Horse, Salernitano, Andalusian, Ventasso, Italian trotter, 400 
Thoroughbred horse) revealing seven SNPs: two transitions were located in the 401 
promoter region at -646 (GQ183900: g.26T>C) and -156 (GQ183900: g.156T>C) bp 402 
upstream from the start codon and are associated with breeds of different 403 
morphological types. The g.26T>C SNP was polymorphic in 6/16 breeds with higher 404 
observed frequency of the g.26C allele. The g.156T>C polymorphism was detected 405 
in 11/16 breeds and was identified in homozygous condition in a few Bardigiano, 406 
Haflinger, Noric, Rapid Heavy Draft, and Uruguayan Creole horses (Dall’Olio et al., 407 
2010). The other five SNPs were in intronic regions: four were localized in intron 1 408 
and one in intron 2. Three of the SNPs of intron 1 (g.1634T>G, g.2115A>G, and 409 
g.2327A>C) were also identified in Thoroughbred breeds (Petersen et al., 2013). One 410 
polymorphism (g.2115A>G) has been associated with sprinting ability and racing 411 
stamina in Thoroughbred horses. The association between MSTN and horse racing 412 
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performances was further evidenced by Binns et al. (2010) and Tozaki et al. (2010). 413 
Subsequently 15 Chinese breeds were studied to select the best Chinese domestic 414 
breed to evaluate the potential racing performances (Li et al., 2014). These studies 415 
found six different SNPs in MSTN: two SNPs (g.26T>C and g.156T>C) in the 416 
promoter region, two (g.587A>G and g.598C>T) in the 5’-UTR region, and two 417 
(g.1485C>T, g.2115A> G) in intron-1 of the equine MSTN, respectively. The SNPs 418 
g.587A>G and g.598C>T were novel whereas the others had been previously 419 
reported (Petersen et al., 2013). 420 
Baron et al. (2012) described a genetic variant in exon 2 in some horse breeds. In 421 
fact, they identified a substitution g.2279A>C in Arabians horses and a substitution 422 
g.2478G>C in the Soraia breed horse. 423 
Five polymorphisms (g.66495826T>C, g.66495696T>C, g.66493737T>C, 424 
g.66495254C>T and g.66490010T>C) were recently observed (Stefaniuk et al., 425 
2016) in four Polish breeds (Arabians, Polish Konik, Hucul and Polish Heavy Draft). 426 
The polymorphism g.66495254C>T (also known as g.598C>T), has been described 427 
in Chinese horse breeds as well as in Polish Konik and Arabian horse breeds. The 428 
g.66493737C>T polymorphism known to predict optimum distance in Thoroughbred 429 
horses has been identified in four breeds in Egyptian bloodlines (Bower et al., 2012) 430 
which were introduced to Polish bloodstock through Egyptian stallions. The insertion 431 
g.66495326_66495327Ins227 has been described for the first time in MSTN in 432 
Thoroughbred horses. Recently, it has been found in the American Quarter Horse 433 
(Petersen et al., 2013), and in the Uruguayan Creole breeds (Dall’Olio et al., 2014). 434 
In the Quarter Horse breed, the Ins227 in MSTN is connected with changes to 435 
Gluteus medius muscle fibre proportions. The higher Myosin Heavy Chain 2B fibre 436 
type (fast contracting), is in line with pressure selection in Quarter Horse breed for 437 
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racing performance (Petersen et al., 2013). A summary of the detected genetic 438 
variants in horse is reported in Table 4. 439 
 440 
Myostatin polymorphisms in pig 441 
Jiang et al. (2002) reported three SNPs in porcine MSTN T>A, G>A and C>T, in the 442 
promoter, intron 1 and exon 3, respectively. Only one mutation (T to A) located in the 443 
region 383bp upstream of translation initiation site of porcine MSTN was associated 444 
with average daily gain in the growing period (from 60 to 100 kg of live weight) in 445 
Yorkshire pigs. Furthermore BW in pig with the heterozygous mutation (no AA was 446 
found) was increased (Jiang et al., 2002). 447 
Stinckens et al. (2008) compared the MSTN sequence of Belgian Piétrain, which 448 
shows a heavily muscled phenotype with five other breeds (Piétrain, Landrace, Large 449 
White, Meishan and Wild Boar). Fifteen polymorphic loci were found, three of which 450 
were located in the promoter region (g.435G>A, g.447A>G, and g.879T>A), five in 451 
intron 1 and seven in intron 2. The SNP g.879T>A only appears in Chinese Meishan 452 
pigs whilst the polymorphism located at position 447 of the porcine MSTN promoter 453 
had a very high allele frequency in the Piétrain pig breed. A g.447A>G mutation 454 
which is associated with the expression of the porcine MSTN occurs at the putative 455 
myocyte enhancer factor 3 (MEF3) binding site on the negative DNA strand. This 456 
mutation disrupts a putative MEF3 binding site (Stinckens et al., 2008). 457 
However, these results suggest that naturally occurring MSTN genetic variants 458 
identified thus far in pigs do not have significant association with muscle phenotypes. 459 
Nevertheless, a recent work, using an experimental approach has shown the role of 460 
MSTN in the development of muscle in pigs. Qian et al. (2015) generated MSTN-461 
deficient Meishan pigs using zinc finger nucleases (ZFN) technology coupled with 462 
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somatic cell nucleus transfer. The resulting offspring show remarkable DBM 463 
phenotype especially pronounced in the hindquarters. Muscle in the MSTN null pig 464 
increased mass by 50-100%. Incredibly the muscle fibre size in the null pigs was 465 
smaller than the wild type. All the increase in mass could be attributed to fibre 466 
hyperplasia whereby some muscles from the null had twice the fibre number 467 
compared to wild type. The animals displayed good overall health. As the technology 468 
employed did not involve the introduction of any genetic material in to the genome 469 
(e.g. selection markers), Qian et al. (2015) suggest that it is essentially the same as 470 
double muscle cattle which are used for human consumption.  471 
A summary of the detected genetic variants in pigs is reported in Table 5. 472 
 473 
Myostatin polymorphisms in rabbit 474 
Fontanesi et al. (2011) investigated the variability of the effects of MSTN 475 
polymorphisms on rabbit production traits. Four single SNPs have been identified by 476 
comparative sequencing of 14 rabbits representing breeds or lines having different 477 
conformation and muscle mass: one rare synonymous SNP in exon 1 (c.108C>T), 478 
one synonymous SNP in exon 2 (c.713T>A), one SNP in the 3’-untranslated region 479 
(c.*194A>G) and another SNP in intron 2 (c.747+34C>T) in Belgian hare, Burgundy 480 
fawn, Checkered giant and Giant grey. 481 
In commercial hybrids, Qiao et al. (2014) detected a SNP (T to C) in the 5' regulatory 482 
region, but no mutation sites were detected in the exons. The correlation analysis 483 
showed that the mutation was associated with increased liver and carcass weight. 484 
These results suggest that the mutations in the upstream regulatory region of the 485 
MSTN are beneficial to the rabbit soma development, and the mutations can be used 486 
as molecular markers for the selection of the meat quality in rabbits. Sternstein et al. 487 
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(2014) found polymorphisms in the MSTN in Giant Grey and NZ White breeds. 488 
Comparative sequencing of these breeds revealed two SNPs located in the 489 
regulatory region of the rabbit MSTN (c.-125T>C) and in intron 1 (c.373+234T>C). 490 
A summary of the detected genetic variants in rabbit is reported in Table 6. 491 
 492 
Myostatin polymorphisms in poultry 493 
In chickens MSTN maps to 7p11 (Sazanov et al., 1999), and like that of mammals is 494 
composed of three exons (373 bp, 374 bp and 1567 bp, respectively) and two 495 
introns. Gu et al. (2003) showed poultry MSTN not only regulates skeletal muscle 496 
development, but also participates in the fat metabolism and disposition. This 497 
research team identified seven SNPs: five were in the 5'-regulatory region (G167A, 498 
T177C, G304A, A322G, and C334T) and two were in the 3'-regulatory region of 499 
different chicken lines. These last two SNPs in the 3'-regulatory region of the MSTN 500 
are A to T (7263) and A to G (6935). Ye et al. (2007) studied the association of MSTN 501 
polymorphism with mortality rate, growth, feed conversion efficiency, ultrasound 502 
breast depth, breast percentage, eviscerated carcass weight, leg defects, blood 503 
oxygen level, and hen antibody titer to the infectious bursal disease virus in three 504 
commercial broiler chicken lines. The MSTN had pleiotropic effects on broiler 505 
performance. This conclusion was reached by the discovery of fourteen SNPs: seven 506 
genetic variants in exon 1 (G2100A, G2109A, G2244C, A2283G, C2346T, C2373T, 507 
A2416G), one in exon 2 (T4842G), three in exon 3 (C7434G, A7435G, C7436A), and 508 
three in intron 1 and 2 (A4405C, A4405T and A4954G). 509 
As the main function of MSTN is the regulation of skeletal muscle growth, Ye et al. 510 
(2007) deemed that the non-synonymous SNP T4842G is associated with an amino 511 
acid change in the MSTN and it could be responsible for variability in body weight. 512 
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The Bian chicken breed raised for dual purposes, is an important Chinese breed and 513 
has a 234G>A in exon 1 of the MSTN (Zhang et al., 2012). Other Chinese chicken 514 
breeds (Jinghai, Youxi, and Arbor Acre) have shown four new mutations (A326G, 515 
C334G, C1346T, G1375A) that were located in the 5’-regulatory region (Zhang et al., 516 
2012). Further studies on the growth traits show that the SNPs in chicken MSTN may 517 
affect the abdominal fat weight and percentage, breast muscle weigh and 518 
percentage, birth weight, and adult weight (Zhang et al. 2012). Zhiliang et al. (2004) 519 
identified three SNPs in the 5’ regulatory region and two SNPs in the 3’ regulatory 520 
region, and these differed in allele frequencies between breeds. They found that in 521 
an F2 generation from a cross of broiler and silky chickens, homozygous genotypes 522 
AA and BB at a locus in the 5’ regulatory region have a higher abdominal fat weight 523 
and abdominal fat percentage than AB genotype (Zhiliang et al., 2004). The 524 
upstream promoter region of MSTN was analysed in Wenshang Luhua chicken DNA. 525 
Thirteen E-boxes were identified upstream of MSTN and the polymorphisms of E-526 
boxes were explored for the first time (Hu et al., 2013). 527 
Other interesting studies were carried out on ducks to investigate the association of 528 
polymorphisms in MSTN with slaughter traits, breast muscle weight, breast muscle 529 
percentage, leg muscle weight and leg muscle percentage. Analysis of the 5′ 530 
regulatory region of the MSTN showed that polymorphisms (753G>A, 658G>T and 531 
235G>C) were associated with the breast muscle percentage and abdominal fat rate 532 
(Lu et al., 2011). Furthermore Xu et al. (2013) studied polymorphisms in Pekin duck, 533 
and identified three significant variations. The first is a transition T to C in the ORF 534 
(position 129) and revealed an association with breast muscle thickness. The second 535 
SNP was located at 708 bp for the T/C mutation in the ORF and last 952T<C had a 536 
significant association with the “Fossilia Ossis Mastodi, or dragon bone” length. In 537 
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Gaoyou ducks, a transition G>A at 2701bp in exon 3 of the MSTN is correlated with 538 
the abdominal fat rate (Liu et al., 2012). In Sansui duck, six SNPs were identified in 539 
the first and the third exons (g.106G>A, g.120A>G, g.159G>A, g.5368G>A, 540 
g.5389A>C and g.5410G>A) with four loci seemingly associated to leg muscle 541 
weight, leg muscle percentage and dressing percentage (Zhao et al., 2016).  542 
A summary of the detected genetic variants in poultry is reported in Table 7. 543 
 544 
Myostatin and future implications 545 
According to some investigators, MSTN mutations are the main cause of 546 
hypertrophy, with a lesser roles played by other gene mutations (Kobolák & Gócza, 547 
2002). Inactivation of MSTN has therefore been proposed to be a strategy for 548 
improving muscle growth of food animals and treating human diseases associated 549 
with muscle weakness and dystrophy (Chen & Lee, 2016). 550 
Research, especially on mice, has highlighted the potential of manipulating MSTN 551 
signalling in order to promote muscle growth. In null mutants of this species, some 552 
muscles are approximately three times their normal weight. Impressive as they are, 553 
muscle enlargement in large mammals carrying a null mutation in the same gene, to 554 
our knowledge, do not approach this level of muscle growth. Therefore it is important 555 
to ascertain the molecular basis underpinning these different responses with a view 556 
of translating these findings into increased meat production. 557 
One picture that emerges through this review is that mutations that compromise 558 
MSTN function have a consequence during development and give rise to 559 
supernumerary muscle fibres (hyperplasia). However, one of the clear differences 560 
between mice and large animals (cattle and pigs) is the post-natal phenotype. Mice 561 
show considerable fibre hypertrophy whereas in both cattle and pigs display no 562 
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increase in fibre size. These findings need to be used as a benchmark for future work 563 
on doubling muscle in large animals. First and foremost is the need to understand the 564 
basis of muscle growth in large mammals. Here it is very important to use the correct 565 
terms to describe the phenotype of animals, as often this can lead to 566 
misinterpretations regarding mechanism. Often DBM animals are referred to as being 567 
‘Hypertrophic’. However this could infer fibre enlargement. As we have discussed, 568 
especially in the case of cattle and pig, there is no fibre enlargement. We suggest 569 
that accurate mechanistic descriptors are used when they have been precisely 570 
established and without this proof a more generic term needs to be applied. We 571 
suggest the use of the four following terms: 1) Muscle enlargement through 572 
hyperplasia; 2) Muscle enlargement through hypertrophy; 3) Muscle enlargement 573 
through hyperplasia and hypertrophy; 4) Muscle enlargement through unknown 574 
cellular mechanisms. 575 
Research is required to understand the mechanisms that underpin the role of MSTN 576 
in post-natal muscle development in mammals, to answer the question as to why in 577 
the absence of MSTN, fibres from mice undergo enlargement, whereas those from 578 
large mammals do not. For a number of years the naturally occurring mutants in 579 
cattle were our only reference model for large animals lacking MSTN. The lack of 580 
fibre hypertrophy was usually explained by the presence of a secondary (to date 581 
unidentified) modifying mutation that interfered with the post-natal effect but sparred 582 
the pre-natal phenotype. However the work by Qian et al. (2015) in the pig which 583 
targets only the MSTN undermines the modifying gene idea. Therefore loss of 584 
function mutation in both small and large animals leads to hyperplasia. However it is 585 
only in mice that the mutation has an effect on muscle fibre size where it presents as 586 
hypertrophy. 587 
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Clues to resolving this issue come from recent work in monkeys which shows that 588 
MSTN and Activin act synergistically to inhibit fibre hypertrophy during adult life 589 
(Latres et al., 2017). Based on these findings we suggest that muscle fibres of both 590 
cows and pigs are sensitive to Myostatin/Activin signalling, in a similar manner to 591 
monkeys. But the issue that still needs to be resolved is why do fibres in adult cows 592 
and pigs fail to enlarge in the absence of MSTN. The most parsimonious explanation 593 
is that there is a partial redundancy relationship between MSTN and Activin; in the 594 
absence of MSTN, the expression levels of Activin become elevated to such a 595 
degree that in cows and pigs the latter can completely cover the loss of the former. 596 
Examples of gene expression compensation by related molecules, similar to our 597 
proposal are abound in mammalian biology (Barbaric et al., 2007). One of the best 598 
examples comes through the investigations of MRFs where genetic inactivation of 599 
MyoD results in an up-regulation of the related gene-Myf5 (Rudnicki et al., 1992). 600 
The hypothesis outlined above has a number of important implications. Our assertion 601 
of why the relationship between MSTN and Activin in cows and pigs is only partial 602 
and not complete, come from the fact that loss of MSTN has some phenotypic 603 
consequence (hyperplasia). Therefore compensation through an up-regulation of 604 
Activin expression cannot have occurred during pre-natal life. The second implication 605 
is that if there is a redundancy mechanism in mice, which must be very muted since 606 
these animals develop a profound phenotype both during pre-natal and adult life. Our 607 
suggestions can be validated by quantifying the levels of MSTN and Activin at 608 
different developmental stages in both large and small animals, an avenue now 609 
possible following the development of specific ELISA for MSTN and Activin (Latres et 610 
al., 2017). 611 
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For the meat industry and for the human health sector who focus on muscle growth, 612 
the hypothesis outlined here advocates a strategy of dual MSTN and Activin 613 
antagonism to promote the growth of the tissue. This could be achieved through the 614 
use of a combination of molecules that specifically antagonise the activity of MSTN 615 
and Activin (antibodies or protein specific propeptides) or a single protein which acts 616 
at a signalling convergence point (at the receptor level through the deployment of a 617 
ligand trap or blocking antibody (Omairi et al., 2016, Lach-Trifilieff et al., 2014). 618 
Moreover for beef production it will be very interesting to better understand the role of 619 
MSTN in adipogenesis; Deng et al. (2017) in fact reported that muscle and adipose 620 
tissue develop from the same mesenchymal stem cells, and researchers have found 621 
that MSTN is expressed in fat tissues and plays a key role in adipogenesis. 622 
Finally MSTN is a prime target for transgenic approaches aimed at enhancing meat 623 
production in livestock (Georges, 2010). Possible strategies for this outcome include 624 
the generation of MSTN knock-out animals. Also more elaborate transgenic 625 
approaches, such as targeting post-natal or sex specific inhibition of MSTN need to 626 
be considered. Wang et al. (2017), reported the successful application of the 627 
CRISPR/Cas9 system to engineer the goat genome through micro-injection of Cas9 628 
mRNA and sgRNAs targeting MSTN in goat embryos. They demonstrate the utility of 629 
this approach by disrupting MSTN, resulting in enhanced body weight and larger 630 
muscle fiber size in Cas9-mediated gene modified goats. MSTN activity can also be 631 
modified using non-genetic approaches using for example blocking antibodies or 632 
ligand traps. 633 
 634 
Conclusions 635 
One picture that emerges through this review is that mutations that compromise 636 
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MSTN function have a consequence during development and give rise to 637 
supernumerary muscle fibres (hyperplasia). However, one of the clear differences 638 
between mice and large animals (cattle and pigs) is the post-natal phenotype. First 639 
and foremost there is the need to understand the basis of muscle growth in large 640 
mammals. 641 
This review landscapes the genetics of DBM in mammalian species and chicken and 642 
demonstrates the huge number of genetic variants present in animals of commercial 643 
interest. It also highlights areas where greater research is required in order for 644 
progress to be made concerning the role of MSTN in the regulation of muscle 645 
development in economically important animals. Knowledge of null alleles and 646 
polymorphisms in MSTN are of great interest in the animal breeding field and could 647 
be utilized to improve the selection for meat production in livestock animals. 648 
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LEGENDS TO FIGURES 964 
Figure 1 Myostatin action during myoblast proliferation and differentiation (modified 965 
from Langley et al., 2002). Retinoblastoma protein (Rb), in a low phosphorylated 966 
state, inhibits cell division. Rb activity is attenuated due to hyper-phosphorylation by 967 
the kinase action of CKD2. However the activity of CDK2 is inhibited by p21 which is 968 
induced by the action of MSTN. MSTN also activates Smad2/3 signalling which 969 
inhibits the expression of MyoD which is needed for normal myoblast differentiation. 970 
In the absence of MSTN, the activity of CDK2 is not inhibited which allows it to 971 
inactivate Rb resulting in increased proliferation of myoblasts. At the same time the 972 
expression of MyoD is no longer inhibited by Smad2/3 signalling pathways allowing it 973 
to promote differentiation of the extranumerary myoblasts. 974 
 975 
  976 
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Table 1 Polymorphisms on Myostatin gene in cattle. 977 
 978 
 979 
 980 
 981 
 982 
 983 
 984 
 985 
 986 
 987 
 988 
 989 
 990 
 991 
 992 
 993 
 994 
 995 
 996 
 997 
 998 
 999 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Asturiana de los 
Valles nt821 DEL11 Grobet et al., 1997 
Belgian Blue nt821 DEL11 McPherron & Lee, 1 97 
Blonde 
d’Aquitaine 
nt821 
nt3811 
DEL11 
T>G 
Kambadur et al., 1997 
Bouyer et al., 2014 
Charolaise nt610 C>T Kambadur et al., 1997 
Gasconne nt938 G>A Kambadur et al., 1997 Dunner et al., 2003 
Limousine 
nt821 
nt610 
g.433 
DEL11 
C>T 
C>A 
Kambadur et al., 1997 
Cappuccio et al., 1998 
Sellick et al., 2007 
Maine-Anjou nt419 
nt676 
del-7-ins10 
G>T 
McPherron & Lee, 1997 
Grobet et al., 1997 
Marchigiana g.874 G>T Cappuccio et al., 1998 
Nellore 
nt76 
nt111 
nt267 
nt374 
nt414 
nt420 
nt433 
nt445 
nt527 
nt641 
nt694 
nt840 
nt951 
nt1083 
A>T 
G>T 
A>G 
DEL16 
C>T 
T>G 
A>T 
A>T 
T>A 
G>A 
G>A 
A>G 
T>G 
C>T 
Grisolia et al., 2009 
Parthenoise nt821 DEL11 Kambadur et al., 1997 
Piedmontese nt938 G>A Kambadur et al., 1997 
Rubia Gallega nt821 DEL11 Kambadur et al., 1997 
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Table 2 Polymorphisms on Myostatin gene in sheep. 1000 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Texel 
g.6723 
g+391 
g.2449 
g.2379 
g.1405 
g.1402 
g.1214 
g.1129 
g.41 
g.39 
g+474 
G+613 
g+616 
g+619 
g+622 
g+632 
g+696 
g+3135 
g+4036 
g+4044 
G>A 
G>T 
C>G 
C>T 
A>T 
G>A 
C>T 
C>T 
A>C 
T>C 
C>T 
T>C 
G>A 
T>C 
T>C 
G>T 
C>T 
C>T 
A>C 
C>T 
Kijas et al., 2007 
Norwegian White 
Sheep 
c.960 
c.2360 
DEL1 
G>A Wang et al., 2016 
New Zealand 
Romney 
c.101 
c.-959 
c.-784 
c.373+18 
c.373+563 
c.373+607 
c.374-654 
c.374-54 
c.748-54 
c.*83 
c.*455 
c.*709 
c.*123A 
c.-2449 
c.-2379 
G>A 
C>T 
A>G 
A>G 
A>G 
G>A 
T>C 
T>C 
A>G 
A>G 
C>A 
INSA 
T>G 
G>C 
T>C 
Wang et al., 2016 
 
Kijas et al., 2007 
Charollais c.*123A  Kijas et al., 2007 
White Suffolk c.*123A  Kijas et al., 2007 
Poll Dorset c.*123A  Kijas et al., 2007 
Lincoln c.*123A  Kijas et al., 2007 
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Indian sheep c.539 
c.821 
T>G 
T>A Pothuraju et al., 2015 
Stavropol Merino 
 
c.373+396 
c.374-362 
c.374-16 
c.747+185 
c.748-194 
c.782_783 
c.940 
c.*310 
T>C 
A>T 
DELT 
C>A 
C>A 
INST 
G>T 
G>T 
Trukhachev et al., 2018 
 
 1001 
  1002 
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Table 3 Polymorphisms on Myostatin gene in goat. 1003 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Anhui white g.197  
nt345 
G>A 
A>T 
Zhang et al., 2013 
Nguluma et al., 2018 
Boer 
nt1256 
g.197 
nt1388 
nt345 
nt298 
TTTA/- 
G>A 
T>A 
A>T 
T>C 
Haimen nt1256 TTTA/- 
Motou nt1256 TTTA/- 
Nubi nt1256 TTTA/- 
 1004 
  1005 
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Table 4 Polymorphisms on Myostatin gene in horse. 1006 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
American Quarter 
Horse g.66495326_66495327 INS227 Petersen et al., 2013 
Andalusian 
g.26 
g.156 
g.1634 
g.2024 
g2115 
g.2327 
g.4230 
T>C 
T>C 
T>G 
G>A 
A>G 
A>C 
T>A 
Dall’Olio et al., 2010 
Arabians horses 
g.2279 
g.66495696 
g.66495254 
A>C 
T>C 
C>T 
Baron et al., 2012 
Stefaniuk et al., 2016 
Bardigiano g.156 T>C Dall’Olio et al., 2010 
Haflinger g.156 T>C Dall’Olio et al., 2010 
Hucul 
g.26 
g.66495696 
g.66493737 
g.66490010 
T>C 
T>C 
T>C 
T>C 
Stefaniuk et al., 2014 
Stefaniuk et al., 2016 
Italian Saddle g.26 g.156 
T>C 
T>C Dall’Olio et al., 2010 
Italian trotter g.26 T>C Dall’Olio et al., 2010 
Polish Konik 
g.66495254 
g.66495696 
g.66493737 
g.66495254 
g.66490010 
C>T 
T>C 
T>C 
C>T 
T>C 
Stefaniuk et al., 2014 
Stefaniuk et al., 2016 
Lipizzan g.26 T>C Dall’Olio et al., 2010 
Maremmano g.156 T>C Dall’Olio et al., 2010 
Murgese g.156 T>C Dall’Olio et al., 2010 
Noric g.26 g.156 
T>C 
T>C Dall’Olio et al., 2010 
Polish Heavy Draft 
g.26 
g.66495254 
g.66495696 
g.66493737 
g.66490010 
T>C 
C>T 
T>C 
T>C 
T>C 
Stefaniuk et al., 2014 
Stefaniuk et al., 2016 
Rapid Heavy Draft g.26 g.156 
T>C 
T>C Dall’Olio et al., 2010 
Salernitano g.156 T>C Dall’Olio et al., 2010 
Soraia g.2478 G>C Baron et al., 2012 
Thoroughbred 
horse 
g.156 
g.1634 
g.2115 
g.2327 
T>C 
T>G 
A>G 
A>C 
Dall’Olio et al., 2010 
Petersen et al., 2013 
Petersen et al., 2013 
Petersen et al., 2013 
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Tolfetano g.156 T>C Dall’Olio et al., 2010 
Uruguayan Creole g.156 T>C Dall’Olio et al., 2010 
Ventasso g.26 T>C Dall’Olio et al., 2010 
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Table 5 Polymorphisms on Myostatin gene in pig. 1008 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Belgian Pietrain 
g.435 
g.447 
g.879 
G>A 
A>G 
T>A 
Stinckens et al., 2008 
Chinese Meishan g.879 T>A Qian et al., 2015 
Yorkshire pig 
nt383 
exon 3 
(position no 
specified) 
T>A 
 
G>A 
C>T 
Jiang et al., 2002 
 1009 
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Table 6 Polymorphisms on Myostatin gene in rabbit. 1011 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Belgian hare 
 
c.108 
c.713 
c.*194 
c.747+34 
C>T 
T>A 
A>G 
C>T 
Fontanesi et al., 2013 
Burgundy fawn 
 
c.108 
c.713 
c.*194 
c.747+34 
C>T 
T>A 
A>G 
C>T 
Fontanesi et al., 2013 
Checkered giant 
 
c.108 
c.713 
c.*194 
c.747+34 
C>T 
T>A 
A>G 
C>T 
Fontanesi et al., 2013 
Commercial 
breeds (not 
specified) 
nt476 T>C Qiao et al., 2014 
Giant grey 
c.108 
c.713 
c.*194 
c.747+34 
C>T 
T>A 
A>G 
C>T 
Fontanesi et al., 2013 
Giant Grey c.-125 
c.373+234 
T>C 
T>C Sternstein et al., 2014 
New Zealand 
White 
c.-125 
c.373+234 
T>C 
T>C Sternstein et al., 2014 
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Table 7 Polymorphisms on Myostatin gene in poultry. 1014 
Breed 
Polymorphisms 
on MSTN Reference 
position mutation 
Arbor Acre 
nt167 
nt177 
nt304 
nt322 
nt326 
nt334 
nt334 
nt1346 
nt1375 
nt6935  
nt7263 
G>A 
T>C 
G>A 
A>G 
A>G 
C>T 
C>G 
C>T 
G>A  
A>G 
A>T 
Gu et al., 2003 
Zhang et al., 2012 
 
Bian chicken nt234 G>A Zhang et al., 2012 
Gaoyou ducks nt2701 G>A Liu et al., 2012 
Jinghai 
nt326 
nt334 
nt1346 
nt1375 
A>G 
C>G 
C>T 
G>A 
Zhang et al., 2012 
Pekin duck 
nt129 
nt708 
nt952 
T>C 
T>C 
T>C 
Xu et al., 2013 
Sansui duck 
g.106 
g.120 
g.159 
g.5368 
g.5389 
g.5410 
G>A 
A>G 
G>A 
G>A 
A>C 
G>A 
Zhao et al., 2016 
Youxi 
nt326 
nt334 
nt1346 
nt1375 
A>G 
C>G 
C>T 
G>A 
Zhang et al., 2012 
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